secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2023-04-03T23:59:59+00:00
Accession:  0001558370-23-005339
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne completes $257M investment for 20% stake in Wilson Wolf; future buyout potential $1B
--------------------------------------------------------------------------------

- $257M investment gives Bio-Techne 20% ownership of Wilson Wolf Manufacturing.
- Investment triggered by Wilson Wolf achieving $55M trailing twelve-month EBITDA.
- Bio-Techne has right to acquire remaining 80% for $1B if Wilson Wolf reaches $226M revenue or $136M EBITDA.
- If milestone not met by Dec 31, 2027, acquisition price ~4.4x trailing twelve-month revenue.
- Wilson Wolf develops G-Rex cell production technology for cell and gene therapy; used by over 800 CGT market participants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837023005339/0001558370-23-005339-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837023005339/tmb-20230331x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-005339

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer